SBIR-STTR Award

Auto-Analyzer for Five Hemoglobin Species and Bilirubin
Award last edited on: 2/29/2012

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$784,795
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
John M Steinke

Company Information

Avox Systems Inc (AKA: A-Vox Systems Inc)

12001 Network Boulevard Suite 314
San Antonio, TX 78249
   (210) 695-8242
   pete@avoxsystems.com
   www.avoxsystems.com
Location: Single
Congr. District: 20
County: Bexar

Phase I

Contract Number: 1R43HL044802-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1990
Phase I Amount
$50,000
This project will develop a spectrophotometric instrument to measure the total hemoglobin concentration of whole blood and the relative concentrations of oxy-, deoxy-, carboxy-, met-, and sulfhemoglobin. The chief strategy is to make Beer's Law apply to whole blood by minimizing the effects of light scattering and to employ matrix math techniques to solve for the five hemoglobin concentrations from optical densities measured at five carefully chosen wavelengths. The instrument would have numerous advantages over those now on the market. It would not hemolyze or dilute the blood and would be much less expensive because it would not employ cumbersome plumbing, pumps, or hemolyzers. Unlike existing instruments, it would measure sulfhemoglobin, and its other measurements would not be invalid when sulfhemoglobin is present.Awardee's statement of the potential commercial applications of the research:Unlike existing instruments, this device would not hemolyze the sample. Thus, it would be simpler, more rugged, and much less expensive than those now on the market. The proposed product could be sold to every hospital in the world and to many other clinical labs in which blood gases are measured.National Heart, Lung, and Blood Institute (NHLBI)

Phase II

Contract Number: 2R44HL044802-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1991
(last award dollars: 1992)
Phase II Amount
$734,795

The overall goal of Dr. Steinke's Phase II is to develop a spectrophotometric instrument capable of measuring eight quantities directly in a sample of undiluted whole blood. These include: THb (total hemoglobin concentration); percent Hb02 (percent oxyhemoglobin saturation); percent HbCO (percent carboxyhemoglobin saturation); percent Hi (percent methemoglobin saturation; also known as hemiglobin); percent Hb (percent deoxyhemoglobin saturation); percent SHb (percent sulfhemoglobin saturation); [02] (Hb02 concentration, which approximates oxygen content); and [Bill} (bilirubin concentration). In Phase I, Dr. Steinke developed a prototype spectrophotometer, based on a computer-controlled miniature monochromator, which made measurements in whole blood in spite of blood's well known light scattering properties. To measure the five hemoglobin species and bilirubin requires 6 carefully chosen measuring wavelengths and a 7th wavelength to correct for light scattering; THb and [02] are computed variables not requiring specific wavelengths. The principal aim of Phase II is to evaluate four sources of the 7 monochromatic wavelengths needed for the measurements. The purpose of doing so is to increase the ruggedness of the final design, prove the stability and wavelength stability, and achieve a significant reduction in manufacturing costs. He will fabricate and test four different light sources: (1) Fixed-diffraction grating - multiple light source array. In this light source, individual beams will be focused through seven adjacent input slits onto a single grating. Light enters only one slit at a time because only one lamp at a time will be illuminated. The entrance slits are carefully machined sot that they select each of the 7 desired wavelengths. (2) Hybrid circuit LED array and filter wheel. This light source will consist of an array of seven light emitting diodes(LED's), one for each of the required analytical wavelengths. The emission of each LED will pass through a narrow-band interference filter mounted on a filter wheel. During each measurement cycle, the desired wavelengths will be selected sequentially by rotating the appropriate filter into position in front of the sample and simultaneously energizing the corresponding LED. (3) Special cam monochromator. This light source will consist of a miniature monochromator with a special cam shaft. The special cam will be used to rotate a diffraction grafting, and will have one distinct radius for each of the seven analytical wavelengths. (4) Samarium-neon hollow cathode lamp. Samarium and neon together provide emission wavelengths very close to each of the seven optimal wavelengths to be utilized in Dr. Steinke's device. Light from this source will be sequentially passed through seven filters, each of which will eliminate all wavelengths except the one assigned to that filter.

Thesaurus Terms:
bilirubin, biomedical equipment development, clinical biomedical equipment, hemoglobin, spectrometry blood chemistry